サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1727103

生殖補助医療（ART）の世界市場の評価：製品別、技術別、患者タイプ別、エンドユーザー別、地域別、機会、予測（2018年～2032年）

Assisted Reproductive Technology (ART) Market Assessment, By Product, By Technology, By Patient Type, By End-user, By Region, Opportunities and Forecast, 2018-2032F

出版日
ページ情報
英文 225 Pages
納期
3～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.76円
生殖補助医療（ART）の世界市場の評価：製品別、技術別、患者タイプ別、エンドユーザー別、地域別、機会、予測（2018年～2032年）
出版日: 2025年05月19日
発行: Market Xcel - Markets and Data
ページ情報: 英文 225 Pages
納期: 3～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の生殖補助医療（ART）の市場規模は、2024年の313億6,000万米ドルから2032年に561億7,000万米ドルに達すると予測され、2025年～2032年の予測期間にCAGRで7.56%の成長が見込まれます。市場の拡大は、世界中のさまざまな地域での不妊症の増加、ARTへの投資の増加、さまざまな生殖ソリューションの利用可能性に関する認知の拡大、ARTの認知度とアクセスを高める政府の取り組みの増加によって支えられています。世界保健機関（WHO）は、全世界の成人人口の約17.5%が不妊を経験していると推定しています。

不妊症の割合の増加、ART治療法の急速な進歩、さまざまな生殖ソリューションに関する認知の拡大により、市場は過去の期間に大きく成長し、予測期間も同様の結果を生むと予測されます。ライフスタイルの変化、出産の遅れ、多嚢胞性卵巣症候群（PCOS）や子宮内膜症などの健康状態の有病率の増加などにより、世界中で不妊の課題に直面するカップルが増えているため、こうしたサービスに対する需要が高まっています。

当レポートでは、世界の生殖補助医療（ART）市場について調査分析し、市場規模と予測、市場力学、主要企業の情勢などを提供しています。

目次

第1章 プロジェクトの範囲と定義

第2章 調査手法

第3章 米国関税の影響

第4章 エグゼクティブサマリー

第5章 世界の生殖補助医療（ART）市場の見通し（2018年～2032年）

  • 市場規模の分析と予測
    • 金額
  • 市場シェアの分析と予測
    • 製品別
      • 器具
      • 消耗品
      • 試薬、培地
    • 技術別
      • 体外受精（IVF）
      • 人工授精（AI-IUI）
      • 凍結胚移植（FER）
      • その他の技術
    • 患者タイプ別
      • 男性
      • 女性
    • エンドユーザー別
      • 不妊治療クリニック
      • 病院
      • 手術センター
      • 臨床研究機関
      • その他
    • 地域別
      • 北米
      • 欧州
      • アジア太平洋
      • 南米
      • 中東・アフリカ
    • 市場シェア分析：企業別（上位5社とその他）（金額）（2024年）
  • 市場マップ分析（2024年）
    • 製品別
    • 技術別
    • 患者タイプ別
    • エンドユーザー別
    • 地域別

第6章 北米の生殖補助医療（ART）市場の見通し（2018年～2032年）

  • 市場規模の分析と予測
    • 金額
  • 市場シェアの分析と予測
    • 製品別
      • 器具
      • 消耗品
      • 試薬、培地
    • 技術別
      • 体外受精（IVF）
      • 人工授精（AI-IUI）
      • 凍結胚移植（FER）
      • その他の技術
    • 患者タイプ別
      • 男性
      • 女性
    • エンドユーザー別
      • 不妊治療クリニック
      • 病院
      • 手術センター
      • 臨床研究機関
      • その他
    • シェア：国別
      • 米国
      • カナダ
      • メキシコ
  • 各国の市場の評価
    • 米国の生殖補助医療（ART）市場の見通し（2018年～2032年）
      • 市場規模の分析と予測
      • 市場シェアの分析と予測
    • カナダ
    • メキシコ

第7章 欧州の生殖補助医療（ART）市場の見通し（2018年～2032年）

  • ドイツ
  • フランス
  • イタリア
  • 英国
  • ロシア
  • オランダ
  • スペイン
  • トルコ
  • ポーランド

第8章 アジア太平洋の生殖補助医療（ART）市場の見通し（2018年～2032年）

  • インド
  • 中国
  • 日本
  • オーストラリア
  • ベトナム
  • 韓国
  • インドネシア
  • フィリピン

第9章 南米の生殖補助医療（ART）市場の見通し（2018年～2032年）

  • ブラジル
  • アルゼンチン

第10章 中東・アフリカの生殖補助医療（ART）市場の見通し（2018年～2032年）

  • サウジアラビア
  • アラブ首長国連邦
  • 南アフリカ

第11章 需給分析

第12章 輸入と輸出の分析

第13章 バリューチェーン分析

第14章 ポーターのファイブフォース分析

第15章 PESTLE分析

第16章 価格分析

第17章 市場力学

  • 市場促進要因
  • 市場の課題

第18章 市場動向と発展

第19章 規制枠組みとイノベーション

  • 規制当局の承認

第20章 特許情勢

第21章 ケーススタディ

第22章 競合情勢

  • マーケットリーダー上位5社の競合マトリクス
  • 上位5社のSWOT分析
  • 主要企業上位10社の情勢
    • CooperSurgical, Inc.
    • FUJIFILM Irvine Scientific, Inc.
    • Cook Group Incorporated
    • Thermo Fisher Scientific Inc.
    • Vitrolife Sweden AB
    • Hamilton Thorne Inc.
    • Ferring B.V.
    • Genea Group
    • Esco Lifesciences Group Ltd.
    • Kitazato Corporation

第23章 戦略的提言

第24章 調査会社について・免責事項

図表

List of Tables

  • Table 1. Competition Matrix of Top 5 Market Leaders
  • Table 2. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 3. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Assisted Reproductive Technology (ART) Market, By Value, In USD Billion, 2018-2032F
  • Figure 2. Global Assisted Reproductive Technology (ART) Market Share (%), By Product, 2018-2032F
  • Figure 3. Global Assisted Reproductive Technology (ART) Market Share (%), By Technology, 2018-2032F
  • Figure 4. Global Assisted Reproductive Technology (ART) Market Share (%), By Patient Type, 2018-2032F
  • Figure 5. Global Assisted Reproductive Technology (ART) Market Share (%), By End-user, 2018-2032F
  • Figure 6. Global Assisted Reproductive Technology (ART) Market Share (%), By Region, 2018-2032F
  • Figure 7. North America Assisted Reproductive Technology (ART) Market, By Value, In USD Billion, 2018-2032F
  • Figure 8. North America Assisted Reproductive Technology (ART) Market Share (%), By Product, 2018-2032F
  • Figure 9. North America Assisted Reproductive Technology (ART) Market Share (%), By Technology, 2018-2032F
  • Figure 10. North America Assisted Reproductive Technology (ART) Market Share (%), By Patient Type, 2018-2032F
  • Figure 11. North America Assisted Reproductive Technology (ART) Market Share (%), By End-user, 2018-2032F
  • Figure 12. North America Assisted Reproductive Technology (ART) Market Share (%), By Country, 2018-2032F
  • Figure 13. United States Assisted Reproductive Technology (ART) Market, By Value, In USD Billion, 2018-2032F
  • Figure 14. United States Assisted Reproductive Technology (ART) Market Share (%), By Product, 2018-2032F
  • Figure 15. United States Assisted Reproductive Technology (ART) Market Share (%), By Technology, 2018-2032F
  • Figure 16. United States Assisted Reproductive Technology (ART) Market Share (%), By Patient Type, 2018-2032F
  • Figure 17. United States Assisted Reproductive Technology (ART) Market Share (%), By End-user, 2018-2032F
  • Figure 18. Canada Assisted Reproductive Technology (ART) Market, By Value, In USD Billion, 2018-2032F
  • Figure 19. Canada Assisted Reproductive Technology (ART) Market Share (%), By Product, 2018-2032F
  • Figure 20. Canada Assisted Reproductive Technology (ART) Market Share (%), By Technology, 2018-2032F
  • Figure 21. Canada Assisted Reproductive Technology (ART) Market Share (%), By Patient Type, 2018-2032F
  • Figure 22. Canada Assisted Reproductive Technology (ART) Market Share (%), By End-user, 2018-2032F
  • Figure 23. Mexico Assisted Reproductive Technology (ART) Market, By Value, In USD Billion, 2018-2032F
  • Figure 24. Mexico Assisted Reproductive Technology (ART) Market Share (%), By Product, 2018-2032F
  • Figure 25. Mexico Assisted Reproductive Technology (ART) Market Share (%), By Technology, 2018-2032F
  • Figure 26. Mexico Assisted Reproductive Technology (ART) Market Share (%), By Patient Type, 2018-2032F
  • Figure 27. Mexico Assisted Reproductive Technology (ART) Market Share (%), By End-user, 2018-2032F
  • Figure 28. Europe Assisted Reproductive Technology (ART) Market, By Value, In USD Billion, 2018-2032F
  • Figure 29. Europe Assisted Reproductive Technology (ART) Market Share (%), By Product, 2018-2032F
  • Figure 30. Europe Assisted Reproductive Technology (ART) Market Share (%), By Technology, 2018-2032F
  • Figure 31. Europe Assisted Reproductive Technology (ART) Market Share (%), By Patient Type, 2018-2032F
  • Figure 32. Europe Assisted Reproductive Technology (ART) Market Share (%), By End-user, 2018-2032F
  • Figure 33. Europe Assisted Reproductive Technology (ART) Market Share (%), By Country, 2018-2032F
  • Figure 34. Germany Assisted Reproductive Technology (ART) Market, By Value, In USD Billion, 2018-2032F
  • Figure 35. Germany Assisted Reproductive Technology (ART) Market Share (%), By Product, 2018-2032F
  • Figure 36. Germany Assisted Reproductive Technology (ART) Market Share (%), By Technology, 2018-2032F
  • Figure 37. Germany Assisted Reproductive Technology (ART) Market Share (%), By Patient Type, 2018-2032F
  • Figure 38. Germany Assisted Reproductive Technology (ART) Market Share (%), By End-user, 2018-2032F
  • Figure 39. France Assisted Reproductive Technology (ART) Market, By Value, In USD Billion, 2018-2032F
  • Figure 40. France Assisted Reproductive Technology (ART) Market Share (%), By Product, 2018-2032F
  • Figure 41. France Assisted Reproductive Technology (ART) Market Share (%), By Technology, 2018-2032F
  • Figure 42. France Assisted Reproductive Technology (ART) Market Share (%), By Patient Type, 2018-2032F
  • Figure 43. France Assisted Reproductive Technology (ART) Market Share (%), By End-user, 2018-2032F
  • Figure 44. Italy Assisted Reproductive Technology (ART) Market, By Value, In USD Billion, 2018-2032F
  • Figure 45. Italy Assisted Reproductive Technology (ART) Market Share (%), By Product, 2018-2032F
  • Figure 46. Italy Assisted Reproductive Technology (ART) Market Share (%), By Technology, 2018-2032F
  • Figure 47. Italy Assisted Reproductive Technology (ART) Market Share (%), By Patient Type, 2018-2032F
  • Figure 48. Italy Assisted Reproductive Technology (ART) Market Share (%), By End-user, 2018-2032F
  • Figure 49. United Kingdom Assisted Reproductive Technology (ART) Market, By Value, In USD Billion, 2018-2032F
  • Figure 50. United Kingdom Assisted Reproductive Technology (ART) Market Share (%), By Product, 2018-2032F
  • Figure 51. United Kingdom Assisted Reproductive Technology (ART) Market Share (%), By Technology, 2018-2032F
  • Figure 52. United Kingdom Assisted Reproductive Technology (ART) Market Share (%), By Patient Type, 2018-2032F
  • Figure 53. United Kingdom Assisted Reproductive Technology (ART) Market Share (%), By End-user, 2018-2032F
  • Figure 54. Russia Assisted Reproductive Technology (ART) Market, By Value, In USD Billion, 2018-2032F
  • Figure 55. Russia Assisted Reproductive Technology (ART) Market Share (%), By Product, 2018-2032F
  • Figure 56. Russia Assisted Reproductive Technology (ART) Market Share (%), By Technology, 2018-2032F
  • Figure 57. Russia Assisted Reproductive Technology (ART) Market Share (%), By Patient Type, 2018-2032F
  • Figure 58. Russia Assisted Reproductive Technology (ART) Market Share (%), By End-user, 2018-2032F
  • Figure 59. Netherlands Assisted Reproductive Technology (ART) Market, By Value, In USD Billion, 2018-2032F
  • Figure 60. Netherlands Assisted Reproductive Technology (ART) Market Share (%), By Product, 2018-2032F
  • Figure 61. Netherlands Assisted Reproductive Technology (ART) Market Share (%), By Technology, 2018-2032F
  • Figure 62. Netherlands Assisted Reproductive Technology (ART) Market Share (%), By Patient Type, 2018-2032F
  • Figure 63. Netherlands Assisted Reproductive Technology (ART) Market Share (%), By End-user, 2018-2032F
  • Figure 64. Spain Assisted Reproductive Technology (ART) Market, By Value, In USD Billion, 2018-2032F
  • Figure 65. Spain Assisted Reproductive Technology (ART) Market Share (%), By Product, 2018-2032F
  • Figure 66. Spain Assisted Reproductive Technology (ART) Market Share (%), By Technology, 2018-2032F
  • Figure 67. Spain Assisted Reproductive Technology (ART) Market Share (%), By Patient Type, 2018-2032F
  • Figure 68. Spain Assisted Reproductive Technology (ART) Market Share (%), By End-user, 2018-2032F
  • Figure 69. Turkey Assisted Reproductive Technology (ART) Market, By Value, In USD Billion, 2018-2032F
  • Figure 70. Turkey Assisted Reproductive Technology (ART) Market Share (%), By Product, 2018-2032F
  • Figure 71. Turkey Assisted Reproductive Technology (ART) Market Share (%), By Technology, 2018-2032F
  • Figure 72. Turkey Assisted Reproductive Technology (ART) Market Share (%), By Patient Type, 2018-2032F
  • Figure 73. Turkey Assisted Reproductive Technology (ART) Market Share (%), By End-user, 2018-2032F
  • Figure 74. Poland Assisted Reproductive Technology (ART) Market, By Value, In USD Billion, 2018-2032F
  • Figure 75. Poland Assisted Reproductive Technology (ART) Market Share (%), By Product, 2018-2032F
  • Figure 76. Poland Assisted Reproductive Technology (ART) Market Share (%), By Technology, 2018-2032F
  • Figure 77. Poland Assisted Reproductive Technology (ART) Market Share (%), By Patient Type, 2018-2032F
  • Figure 78. Poland Assisted Reproductive Technology (ART) Market Share (%), By End-user, 2018-2032F
  • Figure 79. South America Assisted Reproductive Technology (ART) Market, By Value, In USD Billion, 2018-2032F
  • Figure 80. South America Assisted Reproductive Technology (ART) Market Share (%), By Product, 2018-2032F
  • Figure 81. South America Assisted Reproductive Technology (ART) Market Share (%), By Technology, 2018-2032F
  • Figure 82. South America Assisted Reproductive Technology (ART) Market Share (%), By Patient Type, 2018-2032F
  • Figure 83. South America Assisted Reproductive Technology (ART) Market Share (%), By End-user, 2018-2032F
  • Figure 84. South America Assisted Reproductive Technology (ART) Market Share (%), By Country, 2018-2032F
  • Figure 85. Brazil Assisted Reproductive Technology (ART) Market, By Value, In USD Billion, 2018-2032F
  • Figure 86. Brazil Assisted Reproductive Technology (ART) Market Share (%), By Product, 2018-2032F
  • Figure 87. Brazil Assisted Reproductive Technology (ART) Market Share (%), By Technology, 2018-2032F
  • Figure 88. Brazil Assisted Reproductive Technology (ART) Market Share (%), By Patient Type, 2018-2032F
  • Figure 89. Brazil Assisted Reproductive Technology (ART) Market Share (%), By End-user, 2018-2032F
  • Figure 90. Argentina Assisted Reproductive Technology (ART) Market, By Value, In USD Billion, 2018-2032F
  • Figure 91. Argentina Assisted Reproductive Technology (ART) Market Share (%), By Product, 2018-2032F
  • Figure 92. Argentina Assisted Reproductive Technology (ART) Market Share (%), By Technology, 2018-2032F
  • Figure 93. Argentina Assisted Reproductive Technology (ART) Market Share (%), By Patient Type, 2018-2032F
  • Figure 94. Argentina Assisted Reproductive Technology (ART) Market Share (%), By End-user, 2018-2032F
  • Figure 95. Asia-Pacific Assisted Reproductive Technology (ART) Market, By Value, In USD Billion, 2018-2032F
  • Figure 96. Asia-Pacific Assisted Reproductive Technology (ART) Market Share (%), By Product, 2018-2032F
  • Figure 97. Asia-Pacific Assisted Reproductive Technology (ART) Market Share (%), By Technology, 2018-2032F
  • Figure 98. Asia-Pacific Assisted Reproductive Technology (ART) Market Share (%), By Patient Type, 2018-2032F
  • Figure 99. Asia-Pacific Assisted Reproductive Technology (ART) Market Share (%), By End-user, 2018-2032F
  • Figure 100. Asia-Pacific Assisted Reproductive Technology (ART) Market Share (%), By Country, 2018-2032F
  • Figure 101. India Assisted Reproductive Technology (ART) Market, By Value, In USD Billion, 2018-2032F
  • Figure 102. India Assisted Reproductive Technology (ART) Market Share (%), By Product, 2018-2032F
  • Figure 103. India Assisted Reproductive Technology (ART) Market Share (%), By Technology, 2018-2032F
  • Figure 104. India Assisted Reproductive Technology (ART) Market Share (%), By Patient Type, 2018-2032F
  • Figure 105. India Assisted Reproductive Technology (ART) Market Share (%), By End-user, 2018-2032F
  • Figure 106. China Assisted Reproductive Technology (ART) Market, By Value, In USD Billion, 2018-2032F
  • Figure 107. China Assisted Reproductive Technology (ART) Market Share (%), By Product, 2018-2032F
  • Figure 108. China Assisted Reproductive Technology (ART) Market Share (%), By Technology, 2018-2032F
  • Figure 109. China Assisted Reproductive Technology (ART) Market Share (%), By Patient Type, 2018-2032F
  • Figure 110. China Assisted Reproductive Technology (ART) Market Share (%), By End-user, 2018-2032F
  • Figure 111. Japan Assisted Reproductive Technology (ART) Market, By Value, In USD Billion, 2018-2032F
  • Figure 112. Japan Assisted Reproductive Technology (ART) Market Share (%), By Product, 2018-2032F
  • Figure 113. Japan Assisted Reproductive Technology (ART) Market Share (%), By Technology, 2018-2032F
  • Figure 114. Japan Assisted Reproductive Technology (ART) Market Share (%), By Patient Type, 2018-2032F
  • Figure 115. Japan Assisted Reproductive Technology (ART) Market Share (%), By End-user, 2018-2032F
  • Figure 116. Australia Assisted Reproductive Technology (ART) Market, By Value, In USD Billion, 2018-2032F
  • Figure 117. Australia Assisted Reproductive Technology (ART) Market Share (%), By Product, 2018-2032F
  • Figure 118. Australia Assisted Reproductive Technology (ART) Market Share (%), By Technology, 2018-2032F
  • Figure 119. Australia Assisted Reproductive Technology (ART) Market Share (%), By Patient Type, 2018-2032F
  • Figure 120. Australia Assisted Reproductive Technology (ART) Market Share (%), By End-user, 2018-2032F
  • Figure 121. Vietnam Assisted Reproductive Technology (ART) Market, By Value, In USD Billion, 2018-2032F
  • Figure 122. Vietnam Assisted Reproductive Technology (ART) Market Share (%), By Product, 2018-2032F
  • Figure 123. Vietnam Assisted Reproductive Technology (ART) Market Share (%), By Technology, 2018-2032F
  • Figure 124. Vietnam Assisted Reproductive Technology (ART) Market Share (%), By Patient Type, 2018-2032F
  • Figure 125. Vietnam Assisted Reproductive Technology (ART) Market Share (%), By End-user, 2018-2032F
  • Figure 126. South Korea Assisted Reproductive Technology (ART) Market, By Value, In USD Billion, 2018-2032F
  • Figure 127. South Korea Assisted Reproductive Technology (ART) Market Share (%), By Product, 2018-2032F
  • Figure 128. South Korea Assisted Reproductive Technology (ART) Market Share (%), By Technology, 2018-2032F
  • Figure 129. South Korea Assisted Reproductive Technology (ART) Market Share (%), By Patient Type, 2018-2032F
  • Figure 130. South Korea Assisted Reproductive Technology (ART) Market Share (%), By End-user, 2018-2032F
  • Figure 131. Indonesia Assisted Reproductive Technology (ART) Market, By Value, In USD Billion, 2018-2032F
  • Figure 132. Indonesia Assisted Reproductive Technology (ART) Market Share (%), By Product, 2018-2032F
  • Figure 133. Indonesia Assisted Reproductive Technology (ART) Market Share (%), By Technology, 2018-2032F
  • Figure 134. Indonesia Assisted Reproductive Technology (ART) Market Share (%), By Patient Type, 2018-2032F
  • Figure 135. Indonesia Assisted Reproductive Technology (ART) Market Share (%), By End-user, 2018-2032F
  • Figure 136. Philippines Assisted Reproductive Technology (ART) Market, By Value, In USD Billion, 2018-2032F
  • Figure 137. Philippines Assisted Reproductive Technology (ART) Market Share (%), By Product, 2018-2032F
  • Figure 138. Philippines Assisted Reproductive Technology (ART) Market Share (%), By Technology, 2018-2032F
  • Figure 139. Philippines Assisted Reproductive Technology (ART) Market Share (%), By Patient Type, 2018-2032F
  • Figure 140. Philippines Assisted Reproductive Technology (ART) Market Share (%), By End-user, 2018-2032F
  • Figure 141. Middle East & Africa Assisted Reproductive Technology (ART) Market, By Value, In USD Billion, 2018-2032F
  • Figure 142. Middle East & Africa Assisted Reproductive Technology (ART) Market Share (%), By Product, 2018-2032F
  • Figure 143. Middle East & Africa Assisted Reproductive Technology (ART) Market Share (%), By Technology, 2018-2032F
  • Figure 144. Middle East & Africa Assisted Reproductive Technology (ART) Market Share (%), By Patient Type, 2018-2032F
  • Figure 145. Middle East & Africa Assisted Reproductive Technology (ART) Market Share (%), By End-user, 2018-2032F
  • Figure 146. Middle East & Africa Assisted Reproductive Technology (ART) Market Share (%), By Country, 2018-2032F
  • Figure 147. Saudi Arabia Assisted Reproductive Technology (ART) Market, By Value, In USD Billion, 2018-2032F
  • Figure 148. Saudi Arabia Assisted Reproductive Technology (ART) Market Share (%), By Product, 2018-2032F
  • Figure 149. Saudi Arabia Assisted Reproductive Technology (ART) Market Share (%), By Technology, 2018-2032F
  • Figure 150. Saudi Arabia Assisted Reproductive Technology (ART) Market Share (%), By Patient Type, 2018-2032F
  • Figure 151. Saudi Arabia Assisted Reproductive Technology (ART) Market Share (%), By End-user, 2018-2032F
  • Figure 152. UAE Assisted Reproductive Technology (ART) Market, By Value, In USD Billion, 2018-2032F
  • Figure 153. UAE Assisted Reproductive Technology (ART) Market Share (%), By Product, 2018-2032F
  • Figure 154. UAE Assisted Reproductive Technology (ART) Market Share (%), By Technology, 2018-2032F
  • Figure 155. UAE Assisted Reproductive Technology (ART) Market Share (%), By Patient Type, 2018-2032F
  • Figure 156. UAE Assisted Reproductive Technology (ART) Market Share (%), By End-user, 2018-2032F
  • Figure 157. South Africa Assisted Reproductive Technology (ART) Market, By Value, In USD Billion, 2018-2032F
  • Figure 158. South Africa Assisted Reproductive Technology (ART) Market Share (%), By Product, 2018-2032F
  • Figure 159. South Africa Assisted Reproductive Technology (ART) Market Share (%), By Technology, 2018-2032F
  • Figure 160. South Africa Assisted Reproductive Technology (ART) Market Share (%), By Patient Type, 2018-2032F
  • Figure 161. South Africa Assisted Reproductive Technology (ART) Market Share (%), By End-user, 2018-2032F
  • Figure 162. By Product Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 163. By Technology Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 164. By Patient Type Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 165. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 166. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2024
目次
Product Code: MX13141

Global assisted reproductive technology (ART) market is projected to witness a CAGR of 7.56% during the forecast period 2025-2032, growing from USD 31.36 billion in 2024 to USD 56.17 billion in 2032. The market's expansion is supported by the increasing incidences of infertility in different regions across the globe, rising investments in ART, growing awareness about the availability of different reproductive solutions, and increasing government initiatives to boost awareness and accessibility of ART. The World Health Organization (WHO) estimates that approximately 17.5% of the adult population across the globe are experiencing infertility.

The market has grown significantly over the historic period and is expected to generate similar results over the forecast period due to increasing rates of infertility, rapid advancements in ART procedures, and growing awareness about different reproductive solutions. The demand for these services has been growing as more couples across the globe face fertility challenges due to lifestyle changes, delayed childbearing, and increasing prevalence of health conditions such as polycystic ovary syndrome (PCOS) and endometriosis.

Technological Advancements Drive Market Growth

Leading fertility providers across the globe are focusing on developing and introducing advanced reproductive technologies, propelling the market's expansion. Advancements in artificial intelligence, micromanipulators, time-lapse imaging systems, and advanced incubators improve the success rate and precision of intracytoplasmic sperm injections and in-vitro fertilization. Artificial intelligence (AI) powered tools assist clinicians in embryo selection, medication dosing, and streamlining clinical operations. Thus, various companies are increasingly focusing on investing in such technologies. For instance, in March 2024, Alife Health partnered with Boston IVF, LLC, to pilot the first AI tools in the United States for IVF medication optimization. The latter is implementing Alife's Stim Assist software, designed for aiding IVF clinicians in retrieving the optimal number of eggs for improved success rate of the procedure.

Rising Government Efforts Support Market Expansion

Increasing efforts by various governments to boost population growth and increase awareness and accessibility to ART services are among the major factors driving the market's growth. Most countries are considering introducing supportive policies and subsidized funding schemes in order to bolster population growth and address infertility. Additionally, national guidelines such as those in France, Germany, and Australia have provided an ethical-legal standardization for ART procedure supervision and patient safety. Moreover, rising research grants and funds for fertility science are fostering technological advancements to increase the accessibility of effective treatments.

Meanwhile, countries with declining birth rates are introducing various policies to encourage family planning, which are expected to drive the market's demand. For instance, the Tokyo Metropolitan Government plans on implementing a four-day workweek from April 2025, to improve workplace flexibility and allow parents to balance family responsibilities.

Fertility Clinics Account for Significant Share of the Market

The high popularity of fertility clinics for availing ART services can be attributed to the comprehensive range of procedures and customized treatment plans offered to the patients. Most of these clinics provide a full spectrum of procedures such as preimplantation genetic testing, sperm and egg freezing, intrauterine insemination, and in-vitro fertilization, among others. Additionally, these clinics are also equipped with advanced technological solutions and infrastructure, as well as skilled medical professionals and counsellors, ensuring higher success rates and improved patient satisfaction.

Furthermore, leading fertility clinics are investing in their expansion and focusing on providing services in previously underserved regions, further supporting the segment's growth and expansion. For instance, in February 2025, Wellnest Fertility Inc. launched the Wellnest Fertility Clinic in Utah, United States, introducing a state-of-the-art facility that delivers comprehensive fertility care with personalized treatment plans and advanced embryo monitoring technology. By incorporating continuous, time-lapse embryo monitoring, the clinic enables embryologists to observe embryo development in real time without disturbing their environment, providing invaluable insights into growth patterns and key developmental milestones. This technology enhances the precision of embryo selection, increases the likelihood of successful pregnancies, and ultimately improves patient outcomes. The expansion of such innovative services by fertility clinics worldwide is expected to boost patient confidence in fertility treatments, reduce geographical barriers to high-quality care, and create significant growth opportunities within the ART market.

Europe Holds Major Market Share

The region's dominance can be attributed to the increasing prevalence of infertility in Europe due to evolving societal norms and delayed childbearing, widespread availability of fertility services, and the presence of favorable legislation and regulations in countries such as the United Kingdom, France, and Belgium. These countries also have generous reimbursement policies, reducing out-of-pocket expenses for the patient population. Furthermore, Europe is also a hub for medical tourism in reproductive health, providing relief from higher treatment costs and restrictive laws. The easy availability and adoption of advanced technologies, including single embryo transfer and preimplantation genetic testing, are bolstering the success rate of ART, further augmenting the market's expansion. Furthermore, Europe estimates that approximately 25 million people in the European Union are affected by infertility.

Meanwhile, the market in North America is expected to witness significant growth in the coming years due to the increasing number of same-sex couples in the country, the availability and acceptance of advanced technologies, and the increasing popularity of single parenthood.

Impact of U.S. Tariffs on Global Assisted Reproductive Technology (ART) Market

These tariffs are expected to affect a significant portion of the medical device industry and influence various facets of the ART market, including international trade dynamics and production costs. Tariffs are also expected to potentially disrupt supply chains, forcing companies to relocate manufacturing processes and seek alternative suppliers, which may not be entirely feasible due to the existing regulatory and infrastructural requirements.

Moreover, manufacturers in the United States might find it challenging to compete internationally if other countries retaliate by introducing their own tariffs, resulting in market fragmentation. Thus, stakeholders in the industry will need to navigate the shift in trade dynamics and increase production costs to adapt and hold their position in the market.

Key Players Landscape and Outlook

In order to improve the treatment outcomes and aid researchers and scientists in advancing reproductive technologies, the key players of the market are focusing on new products. For instance, in July 2023, Thermo Fisher Scientific Inc. launched the Ion ReproSeq PGT-A Kit and the Ion AmpliSeq Polyploidy Kit for preimplantation genetic testing-aneuploidy (PGT-A). PGT-A is used to identify chromosomal abnormalities in embryos, allowing clinicians to select the most viable embryos for implantation and improving the success rate of the process. Such launches also provide deeper genomic insights to reproductive researchers, improving reproductive health outcomes and the success rate of pregnancies.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Impact of U.S. Tariffs

4. Executive Summary

5. Global Assisted Reproductive Technology (ART) Market Outlook, 2018-2032F

  • 5.1. Market Size Analysis & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share Analysis & Forecast
    • 5.2.1. By Product
      • 5.2.1.1. Instruments
        • 5.2.1.1.1. Sperm Separators
        • 5.2.1.1.2. Embryo Incubators
        • 5.2.1.1.3. Cryosystems
        • 5.2.1.1.4. Other Instruments
      • 5.2.1.2. Consumables
        • 5.2.1.2.1. Culture Dishes and Plates
        • 5.2.1.2.2. Storage Vials
        • 5.2.1.2.3. Needles
        • 5.2.1.2.4. Embryo Transfer Catheters
        • 5.2.1.2.5. Other Consumables
      • 5.2.1.3. Reagents and Media
        • 5.2.1.3.1. Embryo Culture Media
        • 5.2.1.3.2. Cryopreservation Media
        • 5.2.1.3.3. Semen Processing Media
    • 5.2.2. By Technology
      • 5.2.2.1. In-vitro Fertilization (IVF)
      • 5.2.2.2. Artificial Insemination (AI-IUI)
      • 5.2.2.3. Frozen Embryo Replacement (FER)
      • 5.2.2.4. Other Technologies
    • 5.2.3. By Patient Type
      • 5.2.3.1. Male
      • 5.2.3.2. Female
    • 5.2.4. By End-user
      • 5.2.4.1. Fertility Clinics
      • 5.2.4.2. Hospitals
      • 5.2.4.3. Surgical Centers
      • 5.2.4.4. Clinical Research Institutes
      • 5.2.4.5. Others
    • 5.2.5. By Region
      • 5.2.5.1. North America
      • 5.2.5.2. Europe
      • 5.2.5.3. Asia-Pacific
      • 5.2.5.4. South America
      • 5.2.5.5. Middle East and Africa
    • 5.2.6. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2024)
  • 5.3. Market Map Analysis, 2024
    • 5.3.1. By Product
    • 5.3.2. By Technology
    • 5.3.3. By Patient Type
    • 5.3.4. By End-user
    • 5.3.5. By Region

6. North America Assisted Reproductive Technology (ART) Market Outlook, 2018-2032F

  • 6.1. Market Size Analysis & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share Analysis & Forecast
    • 6.2.1. By Product
      • 6.2.1.1. Instruments
        • 6.2.1.1.1. Sperm Separators
        • 6.2.1.1.2. Embryo Incubators
        • 6.2.1.1.3. Cryosystems
        • 6.2.1.1.4. Other Instruments
      • 6.2.1.2. Consumables
        • 6.2.1.2.1. Culture Dishes and Plates
        • 6.2.1.2.2. Storage Vials
        • 6.2.1.2.3. Needles
        • 6.2.1.2.4. Embryo Transfer Catheters
        • 6.2.1.2.5. Other Consumables
      • 6.2.1.3. Reagents and Media
        • 6.2.1.3.1. Embryo Culture Media
        • 6.2.1.3.2. Cryopreservation Media
        • 6.2.1.3.3. Semen Processing Media
    • 6.2.2. By Technology
      • 6.2.2.1. In-vitro Fertilization (IVF)
      • 6.2.2.2. Artificial Insemination (AI-IUI)
      • 6.2.2.3. Frozen Embryo Replacement (FER)
      • 6.2.2.4. Other Technologies
    • 6.2.3. By Patient Type
      • 6.2.3.1. Male
      • 6.2.3.2. Female
    • 6.2.4. By End-user
      • 6.2.4.1. Fertility Clinics
      • 6.2.4.2. Hospitals
      • 6.2.4.3. Surgical Centers
      • 6.2.4.4. Clinical Research Institutes
      • 6.2.4.5. Others
    • 6.2.5. By Country Share
      • 6.2.5.1. United States
      • 6.2.5.2. Canada
      • 6.2.5.3. Mexico
  • 6.3. Country Market Assessment
    • 6.3.1. United States Assisted Reproductive Technology (ART) Market Outlook, 2018-2032F*
      • 6.3.1.1. Market Size Analysis & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share Analysis & Forecast
        • 6.3.1.2.1. By Product
          • 6.3.1.2.1.1. Instruments
          • 6.3.1.2.1.1.1. Sperm Separators
          • 6.3.1.2.1.1.2. Embryo Incubators
          • 6.3.1.2.1.1.3. Cryosystems
          • 6.3.1.2.1.1.4. Other Instruments
          • 6.3.1.2.1.2. Consumables
          • 6.3.1.2.1.2.1. Culture Dishes and Plates
          • 6.3.1.2.1.2.2. Storage Vials
          • 6.3.1.2.1.2.3. Needles
          • 6.3.1.2.1.2.4. Embryo Transfer Catheters
          • 6.3.1.2.1.2.5. Other Consumables
          • 6.3.1.2.1.3. Reagents and Media
          • 6.3.1.2.1.3.1. Embryo Culture Media
          • 6.3.1.2.1.3.2. Cryopreservation Media
          • 6.3.1.2.1.3.3. Semen Processing Media
        • 6.3.1.2.2. By Technology
          • 6.3.1.2.2.1. In-vitro Fertilization (IVF)
          • 6.3.1.2.2.2. Artificial Insemination (AI-IUI)
          • 6.3.1.2.2.3. Frozen Embryo Replacement (FER)
          • 6.3.1.2.2.4. Other Technologies
        • 6.3.1.2.3. By Patient Type
          • 6.3.1.2.3.1. Male
          • 6.3.1.2.3.2. Female
        • 6.3.1.2.4. By End-user
          • 6.3.1.2.4.1. Fertility Clinics
          • 6.3.1.2.4.2. Hospitals
          • 6.3.1.2.4.3. Surgical Centers
          • 6.3.1.2.4.4. Clinical Research Institutes
          • 6.3.1.2.4.5. Others
    • 6.3.2. Canada
    • 6.3.3. Mexico

All segments will be provided for all regions and countries covered

7. Europe Assisted Reproductive Technology (ART) Market Outlook, 2018-2032F

  • 7.1. Germany
  • 7.2. France
  • 7.3. Italy
  • 7.4. United Kingdom
  • 7.5. Russia
  • 7.6. Netherlands
  • 7.7. Spain
  • 7.8. Turkey
  • 7.9. Poland

8. Asia-Pacific Assisted Reproductive Technology (ART) Market Outlook, 2018-2032F

  • 8.1. India
  • 8.2. China
  • 8.3. Japan
  • 8.4. Australia
  • 8.5. Vietnam
  • 8.6. South Korea
  • 8.7. Indonesia
  • 8.8. Philippines

9. South America Assisted Reproductive Technology (ART) Market Outlook, 2018-2032F

  • 9.1. Brazil
  • 9.2. Argentina

10. Middle East and Africa Assisted Reproductive Technology (ART) Market Outlook, 2018-2032F

  • 10.1. Saudi Arabia
  • 10.2. UAE
  • 10.3. South Africa

11. Demand Supply Analysis

12. Import and Export Analysis

13. Value Chain Analysis

14. Porter's Five Forces Analysis

15. PESTLE Analysis

16. Pricing Analysis

17. Market Dynamics

  • 17.1. Market Drivers
  • 17.2. Market Challenges

18. Market Trends and Developments

19. Regulatory Framework and Innovation

  • 19.1. Regulatory Approvals

20. Patent Landscape

21. Case Studies

22. Competitive Landscape

  • 22.1. Competition Matrix of Top 5 Market Leaders
  • 22.2. SWOT Analysis for Top 5 Players
  • 22.3. Key Players Landscape for Top 10 Market Players
    • 22.3.1. CooperSurgical, Inc.
      • 22.3.1.1. Company Details
      • 22.3.1.2. Key Management Personnel
      • 22.3.1.3. Products and Services
      • 22.3.1.4. Financials (As Reported)
      • 22.3.1.5. Key Market Focus and Geographical Presence
      • 22.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
    • 22.3.2. FUJIFILM Irvine Scientific, Inc.
    • 22.3.3. Cook Group Incorporated
    • 22.3.4. Thermo Fisher Scientific Inc.
    • 22.3.5. Vitrolife Sweden AB
    • 22.3.6. Hamilton Thorne Inc.
    • 22.3.7. Ferring B.V.
    • 22.3.8. Genea Group
    • 22.3.9. Esco Lifesciences Group Ltd.
    • 22.3.10. Kitazato Corporation

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

23. Strategic Recommendations

24. About Us and Disclaimer